» Articles » PMID: 38891862

SARS-CoV-2 Selectively Induces the Expression of Unproductive Splicing Isoforms of Interferon, Class I MHC, and Splicing Machinery Genes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38891862
Authors
Affiliations
Soon will be listed here.
Abstract

RNA processing is a highly conserved mechanism that serves as a pivotal regulator of gene expression. Alternative processing generates transcripts that can still be translated but lead to potentially nonfunctional proteins. A plethora of respiratory viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), strategically manipulate the host's RNA processing machinery to circumvent antiviral responses. We integrated publicly available omics datasets to systematically analyze isoform-level expression and delineate the nascent peptide landscape of SARS-CoV-2-infected human cells. Our findings explore a suggested but uncharacterized mechanism, whereby SARS-CoV-2 infection induces the predominant expression of unproductive splicing isoforms in key IFN signaling, interferon-stimulated (ISGs), class I MHC, and splicing machinery genes, including , , and . In stark contrast, cytokine and chemokine genes, such as and , predominantly express productive (protein-coding) splicing isoforms in response to SARS-CoV-2 infection. We postulate that SARS-CoV-2 employs an unreported tactic of exploiting the host splicing machinery to bolster viral replication and subvert the immune response by selectively upregulating unproductive splicing isoforms from antigen presentation and antiviral response genes. Our study sheds new light on the molecular interplay between SARS-CoV-2 and the host immune system, offering a foundation for the development of novel therapeutic strategies to combat COVID-19.

References
1.
Fisette O, Schroder G, Schafer L . Atomistic structure and dynamics of the human MHC-I peptide-loading complex. Proc Natl Acad Sci U S A. 2020; 117(34):20597-20606. PMC: 7456110. DOI: 10.1073/pnas.2004445117. View

2.
Bruni D, Chazal M, Sinigaglia L, Chauveau L, Schwartz O, Despres P . Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons. Sci Signal. 2015; 8(366):ra25. DOI: 10.1126/scisignal.aaa1552. View

3.
Lokugamage K, Hage A, de Vries M, Valero-Jimenez A, Schindewolf C, Dittmann M . Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. J Virol. 2020; 94(23). PMC: 7654262. DOI: 10.1128/JVI.01410-20. View

4.
Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020; 26(6):842-844. DOI: 10.1038/s41591-020-0901-9. View

5.
Wang Z, Marincola F, Rivoltini L, Parmiani G, Ferrone S . Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells. J Exp Med. 1999; 190(2):205-15. PMC: 2195569. DOI: 10.1084/jem.190.2.205. View